Accium Biosciences is categorized under Commercial Medical Research in Seattle, WA and active since 2004.
Accium Biosciences was established in 2004, and today employs 1 to 4, earning Unknown per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 5417110 by the NAICS.
If you are seeking more information, feel free to contact Ali Arjomand, President at the company’s single location by writing to 550 17th Avenue # 550, Seattle, Washington WA 98122 or by phoning (206) 281-3915. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Accium Biosciences |
| Contact Person: | Ali Arjomand, President |
| Address: | 550 17th Avenue # 550, Seattle, Washington 98122 |
| Phone Number: | (206) 281-3915 |
| Website Address: | acciumbio.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 2004 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 5417110 |
| Share This Business: |
Accium Biosciences was started in 2004 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 5417110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Ali Arjomand, President for inquiries that concern Accium Biosciences by calling the company number (206) 281-3915, as your correspondence is most welcome. Additionally, the physical location of the single location of Accium Biosciences can be found at the coordinates 47.60672,-122.31016 as well as the street address 550 17th Avenue # 550 in Seattle, Washington 98122.
For its online presence, you may visit Accium Biosciences’s website at acciumbio.com and engage with its social media outlets through on Twitter and on Facebook.